Literature DB >> 9844944

Is elevation of clinic blood pressure in patients with white coat hypertension who have normal ambulatory blood pressure associated with target organ changes?

P E Owens1, S P Lyons, S A Rodriguez, E T O'Brien.   

Abstract

BACKGROUND: The issue as to whether white coat hypertension is a pathologically significant entity, with associated target organ changes, or that the condition carries the same risk for target organ involvement as normotension, is undecided. Previous studies which have shown pathological correlates between white coat hypertension and target organ damage have not controlled for the most obvious confounder, mean 24 h blood pressure (BP). METHODS AND
RESULTS: In this study we retrospectively identified 33 age and sex-matched pairs, one group with normal BP, the other with white coat hypertension. The white coat hypertensive group showed significantly greater left ventricular mass indexed for body surface area than normal controls (99.0 g/m2 vs 78.3 g/m2, P < 0.001). The population was then further matched for 24-h mean BP (20 pairs), and was again compared for cardiac muscle changes. The significantly increased left ventricular mass index in the white coat population remained after controlling for 24-h mean BP (101.1 g/m2 vs 81.0 g/m2, P < 0.021).
CONCLUSION: White coat hypertension is indeed associated with a larger left ventricular muscle mass than normotensives and these changes are independent of the actual 24-h BP load, and may reflect increased BP lability, sympathetic nervous system derangement, or a genetic propensity in people with white coat hypertension to stress-related hypertensive reactions, as part of a pre-hypertensive state.

Entities:  

Mesh:

Year:  1998        PMID: 9844944     DOI: 10.1038/sj.jhh.1000721

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  8 in total

Review 1.  Use and interpretation of ambulatory blood pressure monitoring: recommendations of the British hypertension society.

Authors:  E O'Brien; A Coats; P Owens; J Petrie; P L Padfield; W A Littler; M de Swiet; F Mee
Journal:  BMJ       Date:  2000-04-22

2.  Parity as a factor affecting the white-coat effect in pregnant women: the BOSHI study.

Authors:  Mami Ishikuro; Taku Obara; Hirohito Metoki; Takayoshi Ohkubo; Noriyuki Iwama; Mikiko Katagiri; Hidekazu Nishigori; Yoko Narikawa; Katsuyo Yagihashi; Masahiro Kikuya; Nobuo Yaegashi; Kazuhiko Hoshi; Masakuni Suzuki; Shinichi Kuriyama; Yutaka Imai
Journal:  Hypertens Res       Date:  2015-08-27       Impact factor: 3.872

Review 3.  The circadian nuances of hypertension: a reappraisal of 24-h ambulatory blood pressure measurement in clinical practice.

Authors:  E O'Brien
Journal:  Ir J Med Sci       Date:  2007-04-24       Impact factor: 1.568

4.  Clinical trials report. White-coat hypertension and stroke incidence.

Authors:  Domenic A Sica
Journal:  Curr Hypertens Rep       Date:  2005-08       Impact factor: 5.369

Review 5.  Modern approaches to blood pressure measurement.

Authors:  J A Staessen; E T O'Brien; L Thijs; R H Fagard
Journal:  Occup Environ Med       Date:  2000-08       Impact factor: 4.402

6.  Italian society of hypertension guidelines for conventional and automated blood pressure measurement in the office, at home and over 24 hours.

Authors:  Gianfranco Parati; Stefano Omboni; Paolo Palatini; Damiano Rizzoni; Grzegorz Bilo; Mariaconsuelo Valentini; Enrico Agabiti Rosei; Giuseppe Mancia
Journal:  High Blood Press Cardiovasc Prev       Date:  2013-01-22

7.  Left ventricular mass index in children with white coat hypertension.

Authors:  Marc B Lande; Cecilia C Meagher; Susan Gross Fisher; Puneet Belani; Hongyue Wang; Megan Rashid
Journal:  J Pediatr       Date:  2008-03-19       Impact factor: 4.406

8.  Should white coat hypertension be treated?

Authors:  Thomas G Pickering
Journal:  J Clin Hypertens (Greenwich)       Date:  2005-09       Impact factor: 3.738

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.